Lantheus Holdings (LNTH) Net Margin (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Net Margin came in at 31.38% in Q1 2026, up 1181.0% year-on-year from 2.45% in Q1 2025, and up 136.02% on a QoQ basis from 13.3% in Q4 2025.

Lantheus Holdings (LNTH) Net Margin (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Net Margin data on file, last reported at 31.38% in Q1 2026.

  • On a quarterly basis, Net Margin rose 1181.0% year-over-year to 31.38% in Q1 2026; TTM through Mar 2026 was 18.05%, a 150.0% increase from a year earlier, with the FY2025 full-year figure at 15.15%, down 522.0% from the prior year.
  • Net Margin for Q1 2026 stood at 31.38%, up from 13.3% in the prior quarter.
  • Over the last five years, Net Margin for LNTH reached as high as 675.76% in Q4 2023 and fell as low as 45.29% in Q4 2022.
  • Historically, Net Margin has averaged 55.33% across 5 years, with a median of 20.57% in 2022.
  • Across the five-year window, Net Margin jumped 72105 bps in 2023 and tumbled 67877 bps in 2024, its largest moves.
  • Year by year, Net Margin stood at 45.29% in 2022, then jumped by 1592 bps to 675.76% in 2023, then plunged by 100 bps to 3.01% in 2024, then soared by 541 bps to 13.3% in 2025, then jumped by 136 bps to 31.38% in 2026.
  • Per Business Quant data, the three most recent Net Margin figures were 31.38% in Q1 2026, 13.3% in Q4 2025, and 7.23% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 31.38%

Historic Data

Download Data
DateValue
Mar 31, 2026 31.38%
Dec 31, 2025 13.30%
Sep 30, 2025 7.23%
Jun 30, 2025 20.83%
Mar 31, 2025 19.57%
Dec 31, 2024 -3.01%
Sep 30, 2024 34.61%
Jun 30, 2024 15.75%
Mar 31, 2024 35.43%
Dec 31, 2023 675.76%
Sep 30, 2023 41.24%
Jun 30, 2023 29.26%
Mar 31, 2023 -0.93%
Dec 31, 2022 -45.29%
Sep 30, 2022 25.59%
Jun 30, 2022 19.25%
Mar 31, 2022 20.57%
Dec 31, 2021 -31.04%
Sep 30, 2021 -13.14%
Jun 30, 2021 -26.38%